解整合素金屬蛋白酶10(ADAM10)真核蛋白
Eukaryotic A Disintegrin And Metalloprotease 10 (ADAM10)
CD156-C; CD156c; MADM; Kuz; CDw156; Kuzbanian protein homolog; Mammalian disintegrin-metalloprotease
- 編號(hào)EPA766Hu62
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源真核表達(dá)
- 宿主293F cell
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞膜, 胞漿, 細(xì)胞質(zhì), 高爾基體
- 預(yù)測(cè)分子量55.2kDa
- 實(shí)際分子量70kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Arg420~Val641 with N-terminal His Tag and C-terminal Fc Region of Human IgG1
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.6
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1567¥ 3918¥ 7836¥ 23508¥ 58770
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. SDS-PAGE
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA766Hu01 | 解整合素金屬蛋白酶10(ADAM10)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA766Hu62 | 解整合素金屬蛋白酶10(ADAM10)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA766Hu61 | 解整合素金屬蛋白酶10(ADAM10)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA766Hu01 | 解整合素金屬蛋白酶10(ADAM10)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA766Hu01 | 抗解整合素金屬蛋白酶10(ADAM10)多克隆抗體 | Flow cytometry. |
| LAA766Hu71 | 解整合素金屬蛋白酶10(ADAM10)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA766Hu22 | 解整合素金屬蛋白酶10(ADAM10)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA766Hu | 解整合素金屬蛋白酶10(ADAM10)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA766Hu | 解整合素金屬蛋白酶10(ADAM10)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Allergy and Clinical Immunology | RAGE processing in chronic airway conditions: Involvement of Staphylococcus aureus and ECP [ScienceDirect: S0091674912003508] |
| British journal of cancer | ADAM10: a new player in breast cancer progression?[PubMed: 26284334] |
| Int Wound J. | From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases.[Pubmed:26991748] |
| International Wound Journal | From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases[pubmed:26991748] |
| Disease Markers | Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results[Pubmed: 31565100] |
| ADAM10 Plasma Levels Predict Worsening in Cognition of Older Adults: A 3-Year Follow-Up Study[] | |
| Alzheimers Research & Therapy | ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study.[33419480] |
| life | High Levels of TNF-|á and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection[] |